Unknown

Dataset Information

0

MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells.


ABSTRACT:

Background

Cancer/testis antigens (CTAs) are a special type of tumor antigen and are believed to act as potential targets for cancer immunotherapy.

Methods

In this study, we first screened a rational CTA MAGE-A1 for lung adenocarcinoma (LUAD) and explored the detailed characteristics of MAGE-A1 in LUAD development through a series of phenotypic experiments. Then, we developed a novel MAGE-A1-CAR-T cell (mCART) using lentiviral vector based on our previous MAGE-A1-scFv. The anti-tumor effects of this mCART were finally investigated in vitro and in vivo.

Results

The results showed striking malignant behaviors of MAGE-A1 in LUAD development, which further validated the rationality of MAGE-A1 as an appropriate target for LUAD treatment. Then, the innovative mCART was successfully constructed, and mCART displayed encouraging tumor-inhibitory efficacy in LUAD cells and xenografts.

Conclusions

Taken together, our data suggest that MAGE-A1 is a promising candidate marker for LUAD therapy and the MAGE-A1-specific CAR-T cell immunotherapy may be an effective strategy for the treatment of MAGE-A1-positive LUAD.

SUBMITTER: Mao Y 

PROVIDER: S-EPMC6805483 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells.

Mao Yuan Y   Fan Weifei W   Hu Hao H   Zhang Louqian L   Michel Jerod J   Wu Yaqin Y   Wang Jun J   Jia Lizhou L   Tang Xiaojun X   Xu Li L   Chen Yan Y   Zhu Jin J   Feng Zhenqing Z   Xu Lin L   Yin Rong R   Tang Qi Q  

Journal of hematology & oncology 20191022 1


<h4>Background</h4>Cancer/testis antigens (CTAs) are a special type of tumor antigen and are believed to act as potential targets for cancer immunotherapy.<h4>Methods</h4>In this study, we first screened a rational CTA MAGE-A1 for lung adenocarcinoma (LUAD) and explored the detailed characteristics of MAGE-A1 in LUAD development through a series of phenotypic experiments. Then, we developed a novel MAGE-A1-CAR-T cell (mCART) using lentiviral vector based on our previous MAGE-A1-scFv. The anti-tu  ...[more]

Similar Datasets

| S-EPMC10340625 | biostudies-literature
| S-EPMC5794762 | biostudies-literature
| S-EPMC9833675 | biostudies-literature
| S-EPMC10046478 | biostudies-literature
| S-EPMC6796553 | biostudies-literature
| S-EPMC4063135 | biostudies-literature
| S-EPMC11293353 | biostudies-literature
| S-EPMC10122994 | biostudies-literature
| S-EPMC5619020 | biostudies-literature
| S-EPMC6380000 | biostudies-literature